Treatment of Psoriasis with Azathioprine

du Vivier, Anthony; Munro, Dowling D.; Verbov, Julian
January 1974
British Medical Journal;1/12/1974, Vol. 1 Issue 5897, p49
Academic Journal
No abstract available.


Related Articles

  • Immunomodulators/tumour necrosis factor antagonists.  // Reactions Weekly;7/22/2006, Issue 1111, p13 

    The article presents a study conducted on patients with Crohn's disease and psoriasis. It states that each patient developed eruptive melanocytic naevi while receiving treatment with azathioprine and alefacept coupled with entaercept and azathioprine respectively. It highlights the formation of...

  • Infliximab.  // Reactions Weekly;8/4/2007, Issue 1163, p16 

    The article describes a case of infliximab-induced palmoplantar pustulosis psoriasis in a 39-year-old woman. The patient received infliximab for the treatment of Shulman fasciitis. An overview of the symptoms developed by the patient consistent with palmoplantar pustulosis psoriasis is...

  • Chapter 7: Systemic therapy. Menter, Alan; Smith, Catherine; Barker, Jonathan // Fast Facts: Psoriasis (Health Press);2008, p68 

    Chapter 7 of the book "Fast Facts: Psoriasis" Third edition is presented. This chapter explains the important factors to consider before starting systemic therapy for psoriasis. One of the things to perform before starting methotrexate therapy is a general physical examination. Several drugs...

  • Prolonged Remission of Psoriasis with Azathioprine Pulse Therapy. Gupta, Ramji // Indian Journal of Dermatology;Jul/Aug2015, Vol. 60 Issue 4, p360 

    Background: Although various therapies used for the treatment of psoriasis are able to produce remission, yet relapses, a common problem, remains frequent. It was observed that treatment with intermittent high dose (IHD) and continuous low dose (CLD) azathioprine can produce prolonged and...

  • Immunosuppressive drugs and anti tumour necrosis factor agents.  // Reactions Weekly;Mar2015, Vol. 1543 Issue 1, p128 

    Several case studies are presented of men patients who developed hepatosplenic T-cell lymphoma after receiving immunosuppressive drugs and anti tumour necrosis factor agents including azathioprine, etanercept, methotrexate, and prednisone as treatment for Chron's disease and psoriasis.

  • Infliximab.  // Reactions Weekly;Mar2014, Vol. 1494 Issue 1, p30 

    An abstract of the article "Improvement of anti-TNF antibody-induced pustular psoriasis by azathioprine," by T. Kayama and colleagues is presented.

  • Mechanisms of Drug Action: The Potential of Dimethylfumarate for the Treatment of Neoplasms. Chen, Andrea Federico; Kirsner, Robert S // Journal of Investigative Dermatology;Jun2011, Vol. 131 Issue 6, p1181 

    A quiz concerning psoriasis treatment is presented.

  • Degrees of Difficulty. Wilson, Fred // Dermatology Times;Jan2003, Vol. 24 Issue 1, p26 

    Focuses on the treatment of psoriasis. Assessment of a patient's treatment program; Treatment modalities for psoriasis; Treatment of scalp psoriasis and psoriatic arthritis; Challenges encountered by dermatologists in treating psoriasis.

  • PSORIASIS BRIEFS.  // Dermatology Times;Aug2003, Vol. 24 Issue 8, p15 

    Reports issues related to the treatment of psoriasis.

  • Infliximab-induced intertriginous psoriasis in patient with Crohn's disease. Mola&, Federica; Motolese, Alberico // Dermatology Reports;2011, Vol. 3 Issue 3, p90 

    Tumor necrosis factor-α (TNFα) inhibition is an effective treatment of moderate-to-severe psoriasis and other diseases (rheumatoid arthritis, ankylosing spondylitis, psoriasis or Crohn's disease). We report a case of a 32- years-old patient affected by Crohn's disease since the age of 25...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics